Are you searching for parts under NSN 6505-01-656-4667? We encourage you to search through our inventory of over 2 billion new and aftermarket parts applicable within the aerospace industry. Owned and operated by ASAP Semiconductor, ASAP Components stocks key parts of NSN 6505-01-656-4667 such as NDC00378-9123-98, NDC00406-9075-76, NDC00591-3213-72, NDC00781-7243-55, NDC49884-0763-78.
The ASAP method incorporates rigorous quality assurance testing, efficient shipping and handling, and unparalleled customer service. No matter how hard the National Stock Number part is to find, the ASAP team will find a sourcing solution.
We are an AS9120B, ISO 9001:2015 certified and FAA AC 0056B accredited company. We are also the only independent distributor with a NO CHINA SOURCING policy. Submit an RFQ today and experience the ASAP method for yourself.
| Item Name | Fentanyl Transdermal System |
| INC Code | 47057 |
| National Item Identification Number (NIIN) | 01-656-4667 (016564667) |
| NCB Code | USA (01) |
| Part Number | Manufacturer | Item Name | QTY | RFQ |
|---|---|---|---|---|
| NDC00378-9123-98 | mylan pharmaceuticals inc | fentanyl transdermal system | Avl | RFQ |
| NDC00406-9075-76 | mallinc krodt inc | fentanyl transdermal system | Avl | RFQ |
| NDC00591-3213-72 | actavis pharma inc | fentanyl transdermal system | Avl | RFQ |
| NDC00781-7243-55 | sandoz inc | fentanyl transdermal system | Avl | RFQ |
| NDC49884-0763-78 | par pharmaceutical inc | fentanyl transdermal system | Avl | RFQ |
| NDC50458-0093-05 | janssen pharmaceuticals inc | fentanyl transdermal system | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CSLZ | Usual Dose | 75 MCG/HR |
| CBBL | Features Provided | INDIVIDUALLY SEALED |
| CRYC | Controlled Substance Classification | SCHEDULE II |
| CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
| MRC | Decoded Requirement | Clear Text Reply |
| Relevant Components for NSN - 6505-01-656-4667, 6505016564667 | ||||
| 6550-01-517-7058 (6550015177058) | 6505-00-935-9826 (6505009359826) | 6505-00-116-8350 (6505001168350) | 6505-01-367-5242 (6505013675242) | |
| 6550-01-375-1100 (6550013751100) | 6550-01-537-5236 (6550015375236) | 6505-01-341-0947 (6505013410947) | 6505-01-169-9573 (6505011699573) | |
| 6505-01-556-2074 (6505015562074) | 6505-01-417-8924 (6505014178924) | 6532-01-469-7517 (6532014697517) | 6505-01-027-2056 (6505010272056) | |
|
Guaranteed on-time |
|
|
Customized and |
|
|
Over 5100 |
|
|
Complete Purchasing |
